Navigation Links
TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen
Date:2/15/2017

SAN FRANCISCO, Feb. 15, 2017 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") announced today that it has entered into a license agreement with Janssen Biotech, Inc. (Janssen) for use of The Trianni Mouse, a best-in-class monoclonal antibody discovery platform.

Distinguished by novel chimeric gene segment design, the Trianni platform provides Janssen with access to a complete human antibody repertoire that has been optimized for the rapid isolation of fully-human therapeutics. "We are very pleased with the Janssen decision to adopt the Trianni Mouse," commented Dr. Matthias Wabl, Ph.D., Chairman and CEO of TRIANNI. "With its highly differentiated features, most notably a full human antibody repertoire assembled from gene segments that are under mouse regulatory control, we are confident the platform will prove extremely productive for Janssen."

About Trianni, Inc.
TRIANNI is a privately held organization, formed in 2010 with a mission to use recent advances in DNA synthesis and genomic modification technology for the development of an optimized therapeutic antibody discovery platform, The Trianni Mouse. The company is headquartered in San Francisco, CA. Additional information about TRIANNI is available through its corporate website, www.trianni.com

Contact
Mandy Boyd
Director of Marketing
1.415.231.0256 [o]
1.866.674.9314
mandy.boyd@trianni.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trianni-signs-licensing-agreement-for-transgenic-mouse-platform-use-with-janssen-300407881.html


'/>"/>
SOURCE Trianni, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. TRIANNI Announces Issuance of Russian Federation Patent
2. THC Signs Definitive Agreement to Purchase Clone Shipper
3. AGC Signs Agreement for Acquisition of Leading Biopharmaceutical CDMO, CMC Biologics
4. Fischer resigns as Neogen director
5. Dovetail Genomics Signs Japan Distribution Agreement
6. Craft Beer Pioneer, Lagunitas, Signs Up to Save $22.5M in Water, Wastewater, and Energy Costs with Cambrian Innovation’s WEPA
7. WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership
8. Oncimmune Signs Agreement with Accu Reference
9. Thought-Leading Physician, Dr. David Agus, Signs on to Advise uBiome
10. South Dakota Mines Signs Collaborative Agreement with Harvard Business School
11. Epsilon Signs New Multi-Year Agreement To Provide Global Database Marketing Services For Worldwide Biotechnology Leader Shire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)... Branford, CT (PRWEB) , ... March 23, 2017 ... ... Counsel, LLC, was recently selected by the Connecticut Technology Council (CTC) as a ... honored at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
(Date:3/22/2017)... ... 2017 , ... Researchers face a fundamental challenge as they ... tissues, bones, even whole organs to implant in people to treat disease or ... the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t fabricate ...
Breaking Biology Technology:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):